Analysed HCW BIOLOGICS INC (HCWB:NASDAQ) News Sources
HCW Biologics Reports Fourth Quarter 2025 and Fiscal Year 2025 Business Highlights and Financial Results
31-03-2026
yahoo.com
HCW Biologics Delivers a Major Update for its T-Cell Engager Program Revealing Mechanism of Action and Validating Tissue Factor as Target for Treatment of Solid Tumors
27-04-2026
yahoo.com
HCW Biologics Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum
30-04-2026
yahoo.com
HCW Biologics Reports First Quarter 2026 Business Highlights and Financial Results
14-05-2026
yahoo.com
HCW Biologics Inc. Announces Pricing of Approximately $4.0 Million Private Placement Offering At-the-Market Under Nasdaq Rules
21-05-2026
yahoo.com
E.F. Hutton & Co. Serves as Sole Placement Agent on HCW Biologics Inc. $4.0 Million Private Placement
22-05-2026
yahoo.com
HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata
16-06-2026
yahoo.com
HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter
30-06-2026
yahoo.com
What is the current price of HCW BIOLOGICS INC (HCWB:NASDAQ)?
The current price of HCW BIOLOGICS INC (HCWB:NASDAQ) is $3.59.
HCW BIOLOGICS INC (HCWB:NASDAQ) absolute price change since previous trading day?
The absolute price change of HCW BIOLOGICS INC (HCWB:NASDAQ) since the previous trading day is $0.16.
HCW BIOLOGICS INC (HCWB:NASDAQ) percentage price change since previous trading day?
The percentage price change of HCW BIOLOGICS INC (HCWB:NASDAQ) since the previous trading day is 4.6647%.
What is the most recent average sentiment score for HCW BIOLOGICS INC (HCWB:NASDAQ)?
The most recent average sentiment score for HCW BIOLOGICS INC (HCWB:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for HCW BIOLOGICS INC (HCWB:NASDAQ)?
The most recent sentiment for HCW BIOLOGICS INC (HCWB:NASDAQ) is .
SEC-8K** Filing Available For HCW BIOLOGICS INC (HCWB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.